PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CEREBRAL EMBOLISM

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CEREBRAL EMBOLISM

PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for the treatment of cerebral embolism enabling the treatment of cerebral embolism without causing intracranial hemorrhage and enabling bolus administration in place of continuous intravenous infusion. SOLUTION: The pharmaceutical composi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KANO TSUNEO, KATAYAMA YOICHI, SUZUKI MASANORI, SASAMATA MICHIHISA
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for the treatment of cerebral embolism enabling the treatment of cerebral embolism without causing intracranial hemorrhage and enabling bolus administration in place of continuous intravenous infusion. SOLUTION: The pharmaceutical composition contains an active amount of a modified tissue plasminogen activator having the amino acid sequence of human tissue plasminogen activator provided that the 92nd to 173rd amino acid residues are deleted and the 275th arginine residue is substituted with glutamic acid residue and a pharmacologically permissible additive.